NASDAQ · JANX

Janux Therapeutics, Inc.

$15.57 +$0.24 (+1.57%) 1D Pre-market
Charting by TradingView

Key Metrics

$934.89M
Market cap
—
P/E · TTM
—
Revenue · TTM
−$114.48M
Net income
EPS · TTM $-1.85
Dividend yield —
Free cash flow −$78.49M
Beta · 1Y 1.23
EBITDA · TTM −$155.00M
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 5
    The stock moved -8.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$934.89M
Enterprise value—
Shares outstanding61.0M
52-wk range$12.12 – $35.34
Avg volume · 20D563.1K
Net cash —
Book value / share$15.24
IndustryPharmaceutical Preparations
ExchangeNASDAQ
About Janux Therapeutics, Inc.
IPO dateJun 11, 2021
Employees108

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S—
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—

Profitability

Gross —
Operating —
Net —
FCF —
ROE / ROIC -11.7% · —

Financial Health

Current ratio17.01
Quick ratio—
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$943.13M

Cash Flow · TTM

Operating CF −$77.55M
Capex −$945.00K
Free cash flow −$78.49M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings